(Orange County Business Journal - 8/29/2010) Beckman Coulter Inc. has formed an executive team to address problems with a profitable heart disease test and expects to start selling it again by next summer.
...
Company Location
BC record contract
Submitted by Anonymous on Thu, 05/08/2010 - 16:10Beckman Coulter today announced a record contract with CML HealthCare ("CML") of Toronto, Canada. According to the company, the deal represents the largest contract of any Canadian diagnostics company for a single testing site.
VWR buy company in New Zealand
Submitted by Anonymous on Thu, 05/08/2010 - 01:51WELLINGTON, Aug 5 - The Directors of EBOS Group are pleased to announce the sale of the company's portfolio of Scientific businesses to VWR International, LLC, USA. The scientific businesses included in the sale are Global Science and Technology in New Zealand and Quantum Scientific and Crown Scientific in Australia.
VWR Facing Civil Rights Violation Charges & Discrimination Lawsuit in New Jersey?
Submitted by Anonymous on Sun, 01/08/2010 - 05:44
DNVP China Biotech Business Mission 2010
Submitted by dnvp on Sun, 25/07/2010 - 19:16DN Venture Partners has been conducting business missions to Asia since 2005, helping top executives and investors from biotech industry gain a broad perspective and in-depth understanding of the sector in Asia. More importantly, we have been helping these organisations establish critical links to the regional biotech industry.
DNVP Japan Biotech Business Mission 2010
Submitted by dnvp on Sat, 24/07/2010 - 19:19The 2010 Japan Biotech Business Mission aims to link up pharma companies that are seeking out potential R&D and business collaborations with Japanese biotech firms. Participants will gain a better understanding of the Japanese biotech scene through direct meetings with innovative Japanese companies and well-connected contacts in the industry including Japanese venture capitalists.
Xencor is Hot Again!
Submitted by Anonymous on Mon, 28/06/2010 - 21:55All you haters, read it and weep:
MorphoSys AG and Xencor Sign License and Collaboration Agreement for Clinical Antibody Program; Xencor Will Receive $13 Million Upfront
6/28/2010
International Stem Cell Corporation Announces Company Update Conference Call. ISCO Chairman Kenneth Aldrich to Discuss 'Status
Submitted by Anonymous on Wed, 09/06/2010 - 21:44International Stem Cell Corporation (OTCBB:ISCO), a California-based biotechnology company creating human stem cell lines through its patented parthenogenetic process that requires no use of fertilized embryos, today announced that it is has scheduled a conference call for June 15, 2010 at 10:00 a.m. PST. ISCO Chairman, Mr.
Sanofi to invest in Japan generic drug maker -Nikkei:Generics consolidation next??
Submitted by Anonymous on Thu, 27/05/2010 - 04:16Sanofi to invest in Japan generic drug maker -Nikkei
Wed May 26, 2010 10:54pm * Sanofi to invest about 5 bln yen in Nichi-iko - Nikkei
Healthcare
* Sanofi to use deal to enter Japan generic market - Nikkei
* Japan generics market growing thanks to govt promotion
* Move will intensify competition, help market expand-analyst
Biotech Showcase™ 2011
Submitted by EBD Group on Wed, 12/05/2010 - 17:57Biotech Showcase™ is a forum devoted to providing biotechnology companies, investors and pharmaceutical executives with an opportunity to meet in one place during the course of one of the largest annual healthcare conference that attracts investors and biopharmaceutical executives from around the world.